Navigation Links
Nuclear physics promises earlier detection of brain tumors with just 1 scan
Date:3/3/2010

s one hundred times more sensitive than existing clinical SPECT systems. This increased sensitivity offers two benefits- either the dose of radiation administered to the patient could be reduced or alternatively more patients could be scanned by one machine in a day if the current dose is used.

These new cutting edge detector systems, designed by the University of Liverpool's Nuclear Physics research group alongside the Nuclear Physics Group at STFC Daresbury Laboratory, are a direct spin out of AGATA (Advanced Gamma Tracking Array), a nuclear physics research and development project with the aim of building the next generation gamma-ray spectrometer. ProSPECTus is funded from STFC's Particle and Nuclear Physics Applied Systems (PNPAS) programme, a scheme aimed at exploiting techniques developed in blue-skies basic research projects like AGATA so as to generate knowledge exchange into the areas of health, security and energy applications.

Dr Andy Boston, the project spokesperson, at the University of Liverpool said: "Not only is ProSPECTus' technology a hundred times more sensitive than that of the traditional Compton camera, it is unique in that it will also be possible to operate it simultaneously with MRI (Magnetic resonance Imaging), which has never been an option due to the MRI's strong magnetic field. In fact, it will be possible to fit this SPECT system retrospectively to the 350 or so existing MRI scanners across the UK. For patients this means fewer appointments, earlier and more effective diagnosis of tumours, which means higher probability of effective treatment. The higher sensitivity camera also offers the scope for shorter imaging time and lower doses of radiation, which is highly beneficial for patients who require frequent scanning. For clinicians, this means that more patients can be seen in a day. This is a truly collaborative effort between the Nuclear Physics Groups both at the University of Liverpool and STFC Daresbury Laborator
'/>"/>

Contact: Wendy Taylor
wendy.taylor@stfc.ac.uk
44-192-560-3232
Science and Technology Facilities Council
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Nuclear Medicine at Summit Medical Group Earns ACR Re-Accreditation
2. Nuclear Power Plant Improves Site Security with Blast Resistant Guard Booth
3. Pennsylvania Health Department Distributing Potassium Iodide to People Living, Working Near Nuclear Power Plants
4. Improving Care for Cardiac Patients is Centerpiece of American Society of Nuclear Cardiology Meeting
5. Landauer Names Douglas R. Gipson Chief Nuclear Executive
6. Senate Honors Nuclear and Uranium Workers With National Day of Remembrance
7. Living With Radiation Conference Commemorating Chernobyl Nuclear Disaster Held at United Nations, Sponsored by New York Eye & Ear Infirmary
8. Genetic changes outside nuclear DNA suspected to trigger more than half of all cancers
9. Kuwait Purchases 5.4 Million Doses of Emergency Nuclear Radiation Drug from Nukepills.com
10. SNMs Mid-Winter Educational Symposium for nuclear medicine and molecular imaging professionals
11. Journal of Nuclear Medicine premiers new, full-color design
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Santa Rosa, California (PRWEB) November 26, 2014 ... be making never before seen reductions in prices of ... and Liposomal Vitamin D3 . Discounts ... only. , GI for Life’s proprietary ColoVite ... leading board-certified gastroenterologists to promote colon health. One easy-to-take ...
(Date:11/26/2014)... IL (PRWEB) November 26, 2014 ... communication management solutions, has been award the ... Magazine. , This award comes as a great ... capabilities within the Lync ecosystem. Specifically, ISI offers ... all modes of Lync communication, including voice, video, ...
(Date:11/26/2014)... November 26, 2014 Medical suction and ... out of 5. This score represents steady growth in ... years to 2014 as a result of swelling demand ... machines, which are largely considered nondiscretionary. IBISWorld market research ... buyers have some degree of flexibility, given the low ...
(Date:11/26/2014)... Baton Rouge, Louisiana (PRWEB) November 26, 2014 ... and neck pain relief and specialists in minimally ... Dr. K. Samer Shamieh into the rapidly growing ... management specialists. The addition coincides with the ... cutting-edge, reliable medical treatment for Louisiana residents who ...
(Date:11/26/2014)... One of the most important and vital decisions a ... is choosing the ideal wedding dress and bridesmaid dresses. ... high quality outfits. Today, BellasDress.com has unveiled its new ... their suitable bridesmaid gowns here at discount prices. , ... scintillating and highlight all their most beautiful features while ...
Breaking Medicine News(10 mins):Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2Health News:Royal Blue Bridesmaid Dresses Now Are Available for Christmas at BellasDress.com 2
... Dialysis Corporation of,America (Nasdaq: DCAI ) ... located at the St. Thomas More Nursing and,Rehabilitation Center, ... St.,Thomas More Center, as well as the surrounding community. ... 24 treatment stations and is currently caring for,approximately 145 ...
... Inc., a Boston-based,award-winning medical tourism facilitator, has ... an Indianapolis-based health benefits company to provide,global ... affiliated health plan,in Wisconsin. Healthbase will handle ... WellPoint members. , ...
... and flu,season, which means misery for kids and the parents trying ... asking parents to resist the urge to give children under,the age ... Such drugs can have serious side effects on the smallest ... drowsiness,difficulty breathing and even death. , "Some ...
... 5 Health-conscious consumers who are,tired of taking several ... smaller,more powerful alternative to fish oil supplements in MegaRed(TM) ... fatty acids combined with,powerful antioxidants, and is three times ... softgel per day -- which is about as small ...
... Jan. 5 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS) ... updates where amongst other things the company addressed several ... that it has finalized its bilateral negotiations with Slavica ... Chem is a spin off of Renuyu Biochem, a ...
... Soliris(R) INCLINE VILLAGE, Nev., and CHESHIRE, Conn., Jan. 5 ... Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN ) today ... license agreement and settlement agreement that resolve the legal disputes ... PDL,s patents known as the Queen et al. patents. ...
Cached Medicine News:Health News:Dialysis Corporation of America Announces Acquisition of Maryland Dialysis Center 2Health News:Healthbase Collaborates with WellPoint to Bring Affordable Medical Tourism Solutions 2Health News:Caution Urged When Giving Kids Cold and Flu Meds 2Health News:Three Times More Powerful Than Fish Oil, MegaRed(TM) Omega-3 Krill Oil Now Available Nationwide 2Health News:Three Times More Powerful Than Fish Oil, MegaRed(TM) Omega-3 Krill Oil Now Available Nationwide 3Health News:Hard To Treat Diseases (HTDS) Completes E Europe Merger 2Health News:Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute 2Health News:Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute 3
(Date:11/26/2014)... 2014 Nanomix Inc., (Nanomix), a ... of mobile diagnostic tests to enable earlier ... pre-hospital settings, today announced it has received ... certification was awarded by the British Standards ... certification bodies. ISO 13485:2003 ...
(Date:11/26/2014)... LONDON , Nov. 25, 2014 Amgen ... AZN ) today announced that AMAGINE-2 TM , a pivotal, ... more than 1,800 patients with moderate-to-severe plaque psoriasis, met its ... and placebo at week 12. Brodalumab 210 mg given every ... shown to be superior to Stelara on the primary endpoint ...
(Date:11/26/2014)... Nov. 26, 2014 China Nepstar Chain Drugstore ... a leading retail drugstore chain in China based on ... unaudited financial results for the third quarter ended September 30, ... 2014: , Same store sales increased by 8.1% ... Revenue increased by 8.1% to RMB738.3 million (US$120.3 million) compared ...
Breaking Medicine Technology:Nanomix Receives ISO 13485:2003 Certification 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 11
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
Medicine Products: